tradingkey.logo

Nexgel Inc

NXGL
查看詳細走勢圖
1.620USD
-0.020-1.22%
收盤 12/19, 16:00美東報價延遲15分鐘
13.19M總市值
虧損本益比TTM

Nexgel Inc

1.620
-0.020-1.22%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

-1.22%

5天

-2.99%

1月

0.00%

6月

-31.36%

今年開始到現在

-63.68%

1年

-65.75%

查看詳細走勢圖

TradingKey Nexgel Inc股票評分

單位: USD 更新時間: 2025-12-19

操作建議

Nexgel Inc當前公司基本面數據相對穩定,增長潛力很大。當前估值合理,在藥品行業排名91/158位。機構持股佔比非常高,近一個月多位分析師給出公司評級為買入。最高目標價6.00。中期看,股價處於下降通道。近一個月,市場表現一般,但公司基本面和技術面得分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Nexgel Inc評分

相關信息

行業排名
91 / 158
全市場排名
226 / 4582
所屬行業
藥品

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

分析師目標

基於 1 分析師
買入
評級
6.000
目標均價
+308.16%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Nexgel Inc亮點

亮點風險
NexGel, Inc. is a provider of healthcare, beauty, and over-the-counter products, including ultra-gentle, high-water-content hydrogels. It is engaged in manufacturing high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. It specializes in custom gels by capitalizing on proprietary manufacturing technologies. The Company operates through two segments: NexGel and CGN. Its Nexgel segment comprises the manufacturing of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, which is based in Langhorne, Pennsylvania. Its CGN segment comprises CG Converting and Packaging, LLC (CGN), a joint venture with C.G. Laboratories Inc. (CG Labs) used for the Company’s converting and packaging business, which is based in Granbury, Texas. Its brands include Silverseal, Hexagels, Turfguard, Kenkoderm, and Silly George.
業績高增長
公司營業收入穩步增長,連續3年增長324.22%
業績增長期
公司處於發展階段,最新年度總收入8.69M美元
估值合理
公司最新PE估值-4.28,處於3年歷史合理位
機構加倉
最新機構持股790.59K股,環比增加7.97%
詹姆斯·西蒙斯持倉
明星投資者詹姆斯·西蒙斯持倉,最新持倉63.45K股

Nexgel Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Nexgel Inc簡介

NexGel, Inc. is a provider of healthcare, beauty, and over-the-counter products, including ultra-gentle, high-water-content hydrogels. It is engaged in manufacturing high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. It specializes in custom gels by capitalizing on proprietary manufacturing technologies. The Company operates through two segments: NexGel and CGN. Its Nexgel segment comprises the manufacturing of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, which is based in Langhorne, Pennsylvania. Its CGN segment comprises CG Converting and Packaging, LLC (CGN), a joint venture with C.G. Laboratories Inc. (CG Labs) used for the Company’s converting and packaging business, which is based in Granbury, Texas. Its brands include Silverseal, Hexagels, Turfguard, Kenkoderm, and Silly George.
公司代碼NXGL
公司Nexgel Inc
CEOLevy (Adam)
網址https://nexgel.com/

常見問題

Nexgel Inc(NXGL)的當前股價是多少?

Nexgel Inc(NXGL)的當前股價是 1.620。

Nexgel Inc 的股票代碼是什麼?

Nexgel Inc的股票代碼是NXGL。

Nexgel Inc股票的52週最高點是多少?

Nexgel Inc股票的52週最高點是4.950。

Nexgel Inc股票的52週最低點是多少?

Nexgel Inc股票的52週最低點是1.450。

Nexgel Inc的市值是多少?

Nexgel Inc的市值是13.19M。

Nexgel Inc的淨利潤是多少?

Nexgel Inc的淨利潤為-3.28M。

現在Nexgel Inc(NXGL)的股票是買入、持有還是賣出?

根據分析師評級,Nexgel Inc(NXGL)的總體評級為買入,目標價格為6.000。

Nexgel Inc(NXGL)股票的每股收益(EPS TTM)是多少

Nexgel Inc(NXGL)股票的每股收益(EPS TTM)是-0.378。
KeyAI